Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction

首次发布于 2007 年 6 月 7 日

Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

计划入组 28 人 · 首次发布于 2019 年 5 月 13 日

Evaluation of Gadoterate in Patients With Renal Dysfunction

计划入组 46 人 · 首次发布于 2015 年 3 月 6 日

Iodixanol(Visipaque, Visipaque 270, Visipaque 320)

C₃₅H₄₄I₆N₆O₁₅ · Rx

alpha-Ketoisocaproic acid

C₆H₁₀O₃

Desmeninol

C₅H₁₀O₃S

River 3 Renal Corp.

United States

Southeast Renal Research Institute

United States

RIVER 2 RENAL CORP.

United States

High-Dose Diuretics and Levosimendan Show Promise in Acute Heart Failure with Renal Dysfunction

FDA Expands ASCENIV Label to Include Pediatric Patients as Young as Two Years for Primary Immunodeficiency Treatment

Roivios' JuxtaFlow Renal Assist Device Receives FDA IDE Approval for Pivotal Trial